Home >
Medicine Info >
Zovair 160 Octacaps
Loading interface...

Zovair 160 Octacaps

Manufactured bySUN PHARMA LABORATORIES LTD
ContainsCiclesonide (160 mcg) + Formoterol (12 mcg) + Tiotropium (18 mcg)
Description
Zovair 160 Octacaps is a combination medicine used to relieve symptoms such as wheezing, shortness of breath, chest tightness, breathing difficulties, coughing, etc. associated with chronic obstructive pulmonary disease (COPD). This medicine is used in severe cases of COPD when treatment with a single medicine and second-line treatment with a combination of two medicines is not able to control the patient's symptoms. This medicine is not recommended for use in patients less than 18 years of age.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Zovair 160 Octacaps

  • Dry mouth
  • Constipation
  • Upper respiratory tract infection
  • Difficult or painful urination
  • Chest pain or discomfort
  • Nausea
  • Mouth ulcers
  • Dizziness
  • Difficulty with swallowing
  • Skin rash, hives, or itching
  • Fainting
  • Body pain
  • Chills
  • Cough or hoarseness
  • Headache
  • Runny Nose
  • Sore throat
  • Unusual tiredness or weakness

Uses of Zovair 160 Octacaps

What is it prescribed for?

  • Chronic obstructive pulmonary disease
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 15 minutes of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to ciclesonide, formoterol, tiotropium, ipratropium, atropine or its derivatives, or any other inactive ingredients present along with these medicines.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.
General warnings

Driving vehicles and operating machinery

This medicine may cause symptoms such as dizziness, fainting, changes in vision, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Glaucoma

This medicine should be used with caution in patients suffering from pre-existing glaucoma due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Urinary retention

This medicine should be used with caution in patients suffering from benign prostatic hyperplasia due to the increased risk of urinary retention. Close monitoring of renal function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Use in children

This medicine is not recommended for use in patients less than 18 years of age.

Tachycardia

This medicine should be used with caution due to the increased risk of tachycardia (increased heart rate) and atrial fibrillation. Report any unusual symptoms such as changes in heart rate, palpitations, shortness of breath, dizziness, etc. to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Angioedema

This medicine should be used with caution due to the increased risk of angioedema. Report any symptoms such as swelling, rashes, hives, etc. immediately to the doctor. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Thyrotoxicosis or hyperthyroidism

This medicine should be used with caution in patients with a known history of thyrotoxicosis or hyperthyroidism due to the increased risk of worsening of the patient's condition. You may require a dose adjustment and more frequent clinical monitoring to safely use this medicine. Replacement with a suitable alternative may be necessary based on the clinical condition.

Hypokalemia

This medicine should be used with caution in patients with a known history of hypokalemia due to the increased risk of worsening of the patient's condition. Close monitoring of potassium levels, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Seizure disorders

This medicine should be used with caution in patients with a known history of seizures due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Visual disturbance

This medicine may cause blurred vision or other visual disturbances in some patients. Report any such symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Tuberculosis

This medicine should be used with extreme caution in patients suffering from tuberculosis due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Infections

This medicine should be used with caution in patients who are at risk of developing infections since it suppresses the immune system and further increases the risk of infections. Any symptoms such as a sore throat, fever, chills, etc. should be reported to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amitriptyline

Atazanavir

Atropine

Amprenavir

Ipratropium

Nefazodone

Doxepin

Itraconazole

Carvedilol

Amiodarone

Cisapride

Clarithromycin

Chlorpheniramine

Ritonavir

Salbutamol

Labetalol

Doxylamine

Disease interactions

Renal Dysfunction

This medicine should be used with caution in patients with a known history of kidney diseases due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Liver Disease

This medicine should be used with caution in patients with a known history of liver diseases since the safety and efficacy of use are not clinically established for such patients. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Cardiovascular disorders

This medicine should be used with caution in patients with a known history of cardiovascular disorders due to the increased risk of serious adverse effects. Report any symptoms such as a headache, dizziness, change in heart rate, palpitations, shortness of breathing, etc. to the doctor immediately. Close monitoring of heart function and vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Ocular herpes simplex

This medicine should be used with caution in patients with an ocular herpes infection due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Infections

This medicine should be used with extreme caution in patients with latent or active infections since this medicine can suppress the immune system and worsen the patient's condition. This risk is especially higher in patients on high doses of this medicine for a prolonged period of time. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Hyperadrenocorticism

This medicine should be used with caution in patients having a high level of adrenal hormones in the body due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Ocular Toxicities

This medicine should be used with extreme caution in patients with a history of cataracts, glaucoma, or increased intraocular pressure due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Use this medicine exactly as prescribed. Do not use it in larger or smaller quantities or for longer than recommended. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Effect on sleep is not established

How it works
This medicine works by relaxing and opening the blocked air passages leading to the lungs. It improves the amount of airflow to the lungs and makes breathing easier. It also inhibits the release of certain substances in the body that cause inflammation (swelling, redness, pain, etc.)
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Bronchodilator combinations

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2018 [cited 8 August 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s006lbl.pdf

[Internet]. Accessdata.fda.gov. 2018 [cited 8 August 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021395s014lbl.pdf

[Internet]. Accessdata.fda.gov. 2018 [cited 8 August 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020831s028lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 15 Oct 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.